Population-based surveillance for scedosporiosis in Australia: Epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection

Clinical Microbiology and Infection

Volumn 15, Issue 7, 2009, Pages 689-693

  Heath, Christopher H ^a   Slavin, Monica A ^b,ag   Sorrell, Tania C ^c   Handke, R ^d   Harun, A ^e   Phillips, M ^f   Nguyen, Quoc ^g   Delhaes, L ^h   Ellis, David ^d   Meyer, Wieland ^e   Chen, Sharon C A ^c,e   Collignon, Peter ⁱ   Benn, Richard ^j   Chambers, Ian ^k   Dennis, Nelson ^l   DeWit, Deo ^m   Ferguson, John ⁿ   Gosbell, Iain ^o   Gottlieb, Thomas ^p   Halliday, Catriona ^c   Holland, Juliette ^q   Kesson, Alison ^r   Lawrence, Richard ^s   Marriott, Deborah ^g   Newton, Peter ^l   Palasanthrian, Pam ^t   Pickles, Robert ^u   Pritchard, Bob ^v   Tierney, Lex ⁿ   Tomasotos, Voula ^o   Vaz, Rob ^w   Weeks, Kerry ^v   Currie, Bart ^x   Allworth, Anthony ^y   Coulter, Christopher ^z   Faoagali, Joan ^y   Johnson, Barbara ^aa   Looke, David ^aa   McCormack, Joseph ^ab   Nimmo, Graeme ^aa   O'Kane, Gabrielle ^z   Playford, E Geoffrey ^aa   Robson, Jennifer ^ac   Rowlands, Karen ^ad   Shaw, David ^ad   Cooley, Louise ^ae   Cox, Erica ^af   McGregor, Alistair ^ae   Franklin, Clare ^ag   Korman, Tony ^ah   Morrissey, Orla ^ag   Spelman, Denis ^ag   Speed, Bryan ^ai   Boan, Peter ^aj   Dyer, John ^ak   Gardam, Dianne ^aj   McLennan, Duncan ^ak   Murray, Ronan ^aj   Pryce, Todd ^aj   more..

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g ST VINCENT S HOSPITAL   (Australia)

^h INSTITUT PASTEUR DE LILLE   (France)

ⁱ CANBERRA HOSPITAL   (Australia)

^j ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^k DOUGLASS HANLY MOIR PATHOLOGY   (Australia)

^l WOLLONGONG HOSPITAL   (Australia)

^m GOSFORD HOSPITAL   (Australia)

ⁿ JOHN HUNTER HOSPITAL   (Australia)

^o LIVERPOOL HOSPITAL   (Australia)

^p Department of Microbiology and Infectious Diseases   (Australia)

^q Mayne Health Laverty Pathology   (Australia)

^r CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^s ST GEORGE HOSPITAL   (Australia)

^t SYDNEY CHILDREN'S HOSPITAL   (Australia)

^u Royal North Shore Hospital ^*

^v ROYAL NORTH SHORE HOSPITAL   (Australia)

^w Orange Base Hospital   (Australia)

^x ROYAL DARWIN HOSPITAL   (Australia)

^y ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^z THE PRINCE CHARLES HOSPITAL   (Australia)

^aa PRINCESS ALEXANDRA HOSPITAL   (Australia)

^ab MATER ADULT HOSPITAL   (Australia)

^ac SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

^ad ROYAL ADELAIDE HOSPITAL   (Australia)

^ae ROYAL HOBART HOSPITAL   (Australia)

^af LAUNCESTON GENERAL HOSPITAL   (Australia)

^ag ALFRED HOSPITAL   (Australia)

^ah MONASH MEDICAL CENTRE   (Australia)

^ai AUSTIN HOSPITAL   (Australia)

^aj ROYAL PERTH HOSPITAL   (Australia)

^ak FREMANTLE HOSPITAL   (Australia)

more..

Author keywords

Epidemiology; Scedosporium; Scedosporium aurantiacum

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; TERBINAFINE; VORICONAZOLE;

ADOLESCENT; ANTIFUNGAL ACTIVITY; ARTICLE; AUSTRALIA; CHRONIC LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; FEMALE; FUNGUS ISOLATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFECTION RISK; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MYCOSIS; NEUTROPENIA; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SCEDOSPORIOSIS; SCEDOSPORIUM; SCEDOSPORIUM APIOSPERMUM; SCEDOSPORIUM AURANTIACUM; STRAIN DIFFERENCE;

SCEDOSPORIUM; SCEDOSPORIUM AURANTIACUM; SCEDOSPORIUM PROLIFICANS;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; AUSTRALIA; FEMALE; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MYCETOMA; POPULATION SURVEILLANCE; RISK FACTORS; SCEDOSPORIUM; YOUNG ADULT;

EID: 68249159677     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02802.x     Document Type: Article

References (21)

1. Husain S, Alexander BD, Munoz P et al. Opportunistic mycelial fangal infections organ transplant recipients: Emerging importance of non- Aspergillus mycelial fungi. Clin Infect Dis 2003; 37: 221-229.
2. Husain S, Munoz P, Forrest G et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005; 40: 89-99.
3. Cortez KJ, Roilides E, Quiroz-Telles F et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008; 21: 157-197.
4. Cimon B, Carrere J, Vinatier JP, Chazalette D, Chabasse D, Bouchara JP. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000; 19: 53-56.
5. Guarro J, Kantarcioglu AS, Horre R et al. Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med Mycol 2006; 44: 295-327.
6. Gilgado F, Cano J, Gene J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: Proposal of two new species. J Clin Microbiol 2005; 43: 4930-4942.
7. Gilgado F, Cano J, Gene J, Sutton DA, Guarro J. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogi. J Clin Microbiol 2008; 46: 766-771.
8. Delhaes L, Harun A, Chen SCA et al. Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum. Emerg Infect Dis 2008; 14: 282-290.
9. Berenguer J, Rodriguez-Tudela JL, Richard C et al. Deep infections caused by Scedosporium prolificans: A report on 16 cases in Spain and a review of the literature. Scedosporium prolificans Spanish Study Group. Medicine (Baltimore) 1997; 76: 256-265.
10. Cooley L, Spelman D, Thursky K, Slavin M. Infections with Scedosporium apiospermum and Scedosporium prolificans in Australia. Emerg Infect Dis 2007; 13: 1170-1177.
11. Castiglioni B, Sutton DA, Rinaldi MG, Fung J, Kusne S. Pseudallescheria boydii (anamorph Scedosporium apiospermum): Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine 2002; 81: 333-348.
12. Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP. Scedosporium infection in a tertiary care cancer center: A review of 25 cases from 1989-2006. Clin Infect Dis 2006; 43: 1580-1584.
13. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
14. de Hoog GS, Guarro J, Gene J, Figueras MJ (eds). Atlas of clinical fungi, 2nd edn. Utrecht: Centraalbureau voor Schimmelcultures/ Universitat Rovira i Virgili, 2000; 305-309 and 899-901.
15. National Committee for Clinical Laboratory Standards (NCCLS). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. NCCLS document M38-A. Wayne, PA: NCCLS, 2002.
16. Australian Bureau of Statistics. Population by age and sex, Australian States and Territories, Canberra: Australian Bureau of Statistics, 2004; 3201.0.
17. Sahi H, Avery RK, Minai OA et al. Scedosporium apiospermum (Pseudallesacheria boydii) infection in lung transplant recipients. J Heart Lung Transplant 2007; 26: 350-356.
18. Symoens F, Knoop C, Schrooyen M et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant 2006; 25: 603-607.
19. Tamm M, Malouf M, Glanville A. Pulmonary Scedosporium infection following lung transplantation. Transpl Infect Dis 2001; 3: 189-194.
20. Gilgado F, Serena C, Cano J, Gene J, Guarro J. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother 2006; 50: 4211-4213.
21. Gilgado F, Cano J, Gene J, Serena C, Guarro J. Different virulence of the species of the Pseudallescheria boydii complex. Med Mycol 2008; 24: 1-4.